Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Chromos Molecular Systems acquires Targeted Molecules Corporation

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Chromos Molecular Systems

On February 2, 2006, Chromos Molecular Systems Inc. announced that it had acquired Targeted Molecules Corporation, a privately held biotechnology company based in San Diego, CA. With the acquisition, Chromos gained two antibody product candidates for treatment of multiple sclerosis and acute thrombosis. Chromos was advised by a team from Fasken Martineau comprised of Iain Mant, Sonya Reiss and Deepak Gill.

Team

    Subscribe

    Receive email updates from our team

    Subscribe